is it safe to take compounded semaglutide (GLP-1) Compounded Semaglutide for Weight Loss

While joint pain relief is not an FDA-approved indication for GLP-1 medications, emerging clinical observations and patient reports have prompted investigation into potential musculoskeletal benefits

It is available as an oral formulation under the brand name Rybelsus and as an injectable medication under the brand name Ozempic

In fact, in the United States, 1 in 3 adults is overweight (defined as a body mass index, or BMI, between 25 and 25.99), and two in five are obese (defined as a BMI over 30)

While undergoing semaglutide treatment, your provider may recommend thyroid function tests (TSH, free T4) at baseline and again at 36 months to ensure your thyroid medication dosing remains appropriate

The common side effects are oily stools, urgency, and reduced absorption of fat-soluble vitamins

Common side effects of Ozempic include: These effects are usually mild and temporary